<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="512">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04275947</url>
  </required_header>
  <id_info>
    <org_study_id>CAALC-008-CMHS</org_study_id>
    <nct_id>NCT04275947</nct_id>
  </id_info>
  <brief_title>The COVID-19 Mobile Health Study (CMHS)</brief_title>
  <acronym>CMHS</acronym>
  <official_title>The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Alliance Against Lung Cancer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Respiratory Research Institution</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Alliance Against Lung Cancer</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates a brand-new cell phone-based auto-diagnosis system, which is based on
      the clinical guidelines, clinical experience, and statistic training model. We will achieve
      secure and 1st hand data from physicians in Wuhan, which including 150 cases in the training
      cohort and 300 cases in the validation cohort.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of nCapp COVID-19 risk diagnostic model</measure>
    <time_frame>1 day</time_frame>
    <description>Sensitivity, specificity and area under the ROC curve of nCapp model</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Training</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Validation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nCapp, a cell phone-based auto-diagnosis system</intervention_name>
    <description>Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19</description>
    <arm_group_label>Training</arm_group_label>
    <arm_group_label>Validation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -High risk of COVID-19
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High risk of COVID-19

          -  RT-PCR test result of SAR2-CoV-19

        Exclusion Criteria:

          -  Not available for RT-PCR test result of SAR2-CoV-19
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Chunxue Bai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Respiratory Research Institution</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chunxue Bai</last_name>
    <phone>+8618621170011â€¬</phone>
    <email>bai.chunxue@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dawei Yang</last_name>
    <phone>+8613564703813</phone>
    <email>yang.dawei@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunxue Bai</last_name>
    </contact>
    <investigator>
      <last_name>Xun Wang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jie Liu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chunlin Dong</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yong Zhang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maosong Ye</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chunxue Bai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Yang D, Zhang X, Powell CA, Ni J, Wang B, Zhang J, Zhang Y, Wang L, Xu Z, Zhang L, Wu G, Song Y, Tian W, Hu JA, Zhang Y, Hu J, Hong Q, Song Y, Zhou J, Bai C. Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study. Cancer. 2018 Jan 15;124(2):262-270. doi: 10.1002/cncr.31020. Epub 2017 Sep 20.</citation>
    <PMID>28940455</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Alliance Against Lung Cancer</investigator_affiliation>
    <investigator_full_name>Bai Chunxue</investigator_full_name>
    <investigator_title>Chair</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The anonymous clinical data for training and validation the model</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

